Do you want to read an article? Please log in or register.
A Two-Staged, Risk-Stratified Strategy Combining FEV(1)/FEV(6) and COPD Diagnostic Questionnaire Acts as an Accurate and Cost-Effective COPD Case-Finding Method
COPD
Related content
COPD
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study
Sci Rep
Ogata H, Tsubouchi K, Takano T, Ichiki K, Torii R, Takata S, Nakagaki N, Yoshida M, Kitasato Y, Tobino K, Harada E, Wataya H, Ishii H, Maeyama T, Kawasaki M, Fujita M, Yatera K, Zaizen Y, Nakanishi Y, Okamoto I
doi: 10.1038/s41598-025-05033-w
RECOMMENDED
COPD
Effects of Baduanjin Exercise on lung function and 6 min walk in COPD patients: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Sci Rep
Song F, Ding K, Qi W, Sun W, Xiang H, Sun M, Xia R
doi: 10.1038/s41598-024-68581-7
RECOMMENDED
COPD
The Effect of Pulmonary Rehabilitation on Cardiovascular Risk, Oxidative Stress and Systemic Inflammation in Patients with COPD
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med
Muñoz Montiel A, Ruiz-Esteban P, Doménech Del Río A, Valdivielso P, Sánchez Chaparro MÁ, Olveira C
doi: 10.1016/j.rmed.2024.107740
Pneumonia
Euthyroid sick syndrome predicts the risk of ischemic stroke-associated pneumonia in the acute stage of ischemic stroke: a nested case-control study
Front Endocrinol (Lausanne)
Yu S, Yan J, Logan R, Tang WT, Ye JN, Feng HX, Wang MX, Xu QR, Jiang XL, Lin HY, Wu GH, Gui Q, Duan TT
doi: 10.3389/fendo.2024.1438700
Further Publications
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
Ther Adv Respir Dis
van Geer-Postmus I, Leving MT, Gerritsma YH, Baan E, Dijk L, Harms E, Price D, Prins GH, Quint JK, Ryan D, Salomé P, Ställberg B, Stoker N, Kocks JH
doi: 10.1177/17534666251329192
COPD
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
Eur Respir J
Wade RC, Martinez FJ, Criner GJ, Tombs L, Lipson DA, Halpin DMG, Han MK, Singh D, Wise RA, Kalhan R, Dransfield MT
doi: 10.1183/13993003.00171-2024
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
RECOMMENDED
COPD
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Higginson IJ, Brown ST, Oluyase AO, May P, Maddocks M, Costantini M, Bajwah S, Normand C, Bausewein C, Simon ST, Ryan K, Currow DC, Johnson MJ, Hart SP, Mather H, Krajnik M, Tanzi S, Ghirotto L, Bolton CE, Janowiak P, Turola E, Jolley CJ, Murden G, Wilcock A, Farsides B, Brown JM, BETTER-B consortium
doi: 10.1016/S2213-2600(24)00187-5
RECOMMENDED
Lung Cancer
Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Harris RA, Stokes EA, Batchelor TJP, Internullo E, West D, Jordan S, Nicholson AG, Paul I, Jacobs C, Shackcloth M, Feeney S, Anikin V, McGonigle N, Steyn R, Kalkat M, Stavroulias D, Havinden Williams M, Qadri S, Dobbs K, Zamvar V, Macdonald L, Kaur S, Rogers CA, Lim E, VIOLET trialists
doi: 10.1016/j.lungcan.2024.108070